7:52AM ET 4/19/2022 MT NewswiresAdicet Bio (ACET) said Tuesday the US Food and Drug Administration has granted fast track designation to ADI-001, a CD20-targeted experimental medicine for...
1:41AM ET 3/31/2022 MT NewswiresAdicet Bio (ACET) has an average rating of buy and price targets ranging from $21 to $35, according to analysts polled by Capital IQ. (MT Newswires covers...
6:53AM ET 3/17/2022 MT NewswiresAdicet Bio (ACET) has an average rating of buy and price targets ranging from $21 to $35, according to analysts polled by Capital IQ. (MT Newswires covers...
3:34AM ET 3/16/2022 MT NewswiresAdicet Bio (ACET) on Tuesday filed a shelf registration statement for the potential sale of up to $500 million of its securities from time to time. The...